KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other Non-Current Liabilities (2016 - 2026)

Pfizer has reported Other Non-Current Liabilities over the past 18 years, most recently at $3.7 billion for Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 35.27% to $3.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.7 billion through Mar 2026, down 35.27% year-over-year, with the annual reading at $3.6 billion for FY2025, 41.25% down from the prior year.
  • Other Non-Current Liabilities was $3.7 billion for Q1 2026 at Pfizer, up from $3.6 billion in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $16.1 billion in Q2 2024 and troughed at $3.6 billion in Q4 2025.
  • The 5-year median for Other Non-Current Liabilities is $8.6 billion (2024), against an average of $9.4 billion.
  • The largest YoY upside for Other Non-Current Liabilities was 130.4% in 2025 against a maximum downside of 41.25% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $13.2 billion in 2022, then plummeted by 35.25% to $8.5 billion in 2023, then fell by 28.38% to $6.1 billion in 2024, then plummeted by 41.25% to $3.6 billion in 2025, then increased by 3.17% to $3.7 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Other Non-Current Liabilities are $3.7 billion (Q1 2026), $3.6 billion (Q4 2025), and $13.6 billion (Q3 2025).